Your initial meeting with the U.S. FDA is a critical step to get your product to market. Unfortunately, many companies go into their FDA meeting unprepared without researching all their options for conducting a successful clinical trial.

Not knowing how to optimize IND/IDE programs wastes resources and lengthens your approval time, potentially letting your competitors beat you to market.

Take the Amarex FDA readiness assessment to see if your product is ready for submission.